Clinical trials
Observational Amyloidosis, Familial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 3 |
| AstraZeneca | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hospital de Alta Complejidad en Red | 1 |
| Rennes University Hospital | 1 |
| RwHealth | 1 |
| University of Sao Paulo General Hospital | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis, Familial | 11 |
| Amyloid Neuropathies, Familial | 6 |
| Amyloidosis | 6 |
| Polyneuropathies | 4 |
| Amyloid Neuropathies | 3 |
| Disease | 1 |
| Disease Progression | 1 |
| Genetic Diseases, Inborn | 1 |
| Guillain-Barre Syndrome | 1 |
| Heredodegenerative Disorders, Nervous System | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.